RAPP
Rapport Therapeutics, Inc. · Healthcare
Chief Executive Officer Abraham Ceesay sold $328K of Rapport Therapeutics, Inc.
Sold$328,437
$40.00Price
8,210Shares
−1%Stake
What RAPP did after the filing
- The stock from Thu, Jul 16 open, $39.81
- +22.5%
- S&P 500, same days
- +2.2%
Measured over 30 trading days, to the Aug 28 close.
Traded Tue, Jul 14. Filed Wed, Jul 15, 4:15 PM ET, after the close. Returns use the Jul 16 open and the Aug 28 close. Not investment advice.